Mathew Angelos, MD, PhD

Assistant Professor, Medicine-Hematology


FacultyPhoto
Medical School
  • MD, University of Minnesota Medical School (2018)
Graduate School
  • PhD, University of Minnesota (2016)
Undergraduate School
  • BSE, Duke University (NC) (2009)
Residency
  • Hospital of the University of Pennsylvania, Internal Medicine (2020)
Fellowships
  • Hospital of the University of Pennsylvania, Hematology and Oncology (2024)
Languages
English
Department
Medicine-Hematology

Professional Titles

  • Assistant Professor of Medicine

Recognitions

  • Research Training Award for Fellows (RTAF), American Society of Hematology (2023)
  • Daniel von Hoff Innovative Protocol Award, AACR-ASCO Methods in Clinical Cancer Research Workshop (2022)
  • Inductee, Alpha Omega Alpha Honor Medical Society (2017)
  • J. Thomas Livermore Award, University of Minnesota Medical School (2017)
  • Veneziale-Steer Award, University of Minnesota Medical School (2017)
  • Abstract Achievement Award, American Society of Hematology (2023)

Publications

  • Brown MA, Wallace CS, Angelos M, Truskey GA. Characterization of umbilical cord blood-derived late outgrowth endothelial progenitor cells exposed to laminar shear stress. Tissue Eng Part A. 2009 Nov;15(11):3575-87. PubMed PMID: 19480571
  • Angelos MG, Brown MA, Satterwhite LL, Levering VW, Shaked NT, Truskey GA. Dynamic adhesion of umbilical cord blood endothelial progenitor cells under laminar shear stress. Biophys J. 2010 Dec 1;99(11):3545-54. PubMed PMID: 21112278
  • Angelos MG, Kaufman DS. Pluripotent stem cell applications for regenerative medicine. Curr Opin Organ Transplant. 2015 Dec;20(6):663-70. PubMed PMID: 26536430
  • Richards MM, Maxwell JS, Weng L, Angelos MG, Golzarian J. Intra-articular treatment of knee osteoarthritis: from anti-inflammatories to products of regenerative medicine. Phys Sportsmed. 2016;44(2):101-8. PubMed PMID: 26985986
  • Angelos MG, Ruh PN, Webber BR, Blum RH, Ryan CD, Bendzick L, Shim S, Yingst AM, Tufa DM, Verneris MR, Kaufman DS. Aryl hydrocarbon receptor inhibition promotes hematolymphoid development from human pluripotent stem cells. Blood. 2017 Jun 29;129(26):3428-3439. PubMed PMID: 28533309
  • Angelos MG, Patel RP, Ruella M, Barta SK. Progress and Pitfalls of Chimeric Antigen Receptor T Cell Immunotherapy against T Cell Malignancies. Transplant Cell Ther. 2024 Feb;30(2):171-186. PubMed PMID: 37866783
  • Patel RP, Ghilardi G, Zhang Y, Chiang YH, Xie W, Guruprasad P, Kim KH, Chun I, Angelos MG, Pajarillo R, Hong SJ, Lee YG, Shestova O, Shaw C, Cohen I, Gupta A, Vu T, Qian D, Yang S, Nimmagadda A, Snook AE, Siciliano N, Rotolo A, Inamdar A, Harris J, Ugwuanyi O, Wang M, Carturan A, Paruzzo L, Chen L, Ballard HJ, Blanchard T, Xu C, Abdel-Mohsen M, Gabunia K, Wysocka M, Linette GP, Carreno B, Barrett DM, Teachey DT, Posey AD, Powell DJ Jr, Sauter CT, Pileri S, Pillai V, Scholler J, Rook AH, Schuster SJ, Barta SK, Porazzi P, Ruella M. CD5 deletion enhances the antitumor activity of adoptive T cell therapies. Sci Immunol. 2024 Jul 19;9(97):eadn6509. PubMed PMID: 39028827
  • Guruprasad P, Carturan A, Zhang Y, Cho JH, Kumashie KG, Patel RP, Kim KH, Lee JS, Lee Y, Kim JH, Chung J, Joshi A, Cohen I, Shestov M, Ghilardi G, Harris J, Pajarillo R, Angelos M, Lee YG, Liu S, Rodriguez J, Wang M, Ballard HJ, Gupta A, Ugwuanyi OH, Hong SJA, Bochi-Layec AC, Sauter CT, Chen L, Paruzzo L, Kammerman S, Shestova O, Liu D, Vella LA, Schuster SJ, Svoboda J, Porazzi P, Ruella M. The BTLA-HVEM axis restricts CAR T cell efficacy in cancer. Nat Immunol. 2024 Jun;25(6):1020-1032. PubMed PMID: 38831106
  • Angelos MG, Abrahante JE, Blum RH, Kaufman DS. Single Cell Resolution of Human Hematoendothelial Cells Defines Transcriptional Signatures of Hemogenic Endothelium. Stem Cells. 2018 Feb;36(2):206-217. PubMed PMID: 29139170
  • Kim JH, Schulte AJ, Sarver AL, Lee D, Angelos MG, Frantz AM, Forster CL, O'Brien TD, Cornax I, O'Sullivan MG, Cheng N, Lewellen M, Oseth L, Kumar S, Bullman S, Pedamallu CS, Goyal SM, Meyerson M, Lund TC, Breen M, Lindblad-Toh K, Dickerson EB, Kaufman DS, Modiano JF. Hemangiosarcoma Cells Promote Conserved Host-derived Hematopoietic Expansion. Cancer Res Commun. 2024 Jun 11;4(6):1467-1480. PubMed PMID: 38757809
  • Angelos MG, Kaufman DS. Advances in the role of the aryl hydrocarbon receptor to regulate early hematopoietic development. Curr Opin Hematol. 2018 Jul;25(4):273-278. PubMed PMID: 29697485
  • Zhang Y, Patel RP, Kim KH, Cho H, Jo JC, Jeong SH, Oh SY, Choi YS, Kim SH, Lee JH, Angelos M, Guruprasad P, Cohen I, Ugwuanyi O, Lee YG, Pajarillo R, Cho JH, Carturan A, Paruzzo L, Ghilardi G, Wang M, Kim S, Kim SM, Lee HJ, Park JH, Cui L, Lee TB, Hwang IS, Lee YH, Lee YJ, Porazzi P, Liu D, Lee Y, Kim JH, Lee JS, Yoon DH, Chung J, Ruella M. Safety and efficacy of a novel anti-CD19 chimeric antigen receptor T cell product targeting a membrane-proximal domain of CD19 with fast on- and off-rates against non-Hodgkin lymphoma: a first-in-human study. Mol Cancer. 2023 Dec 9;22(1):200. PubMed PMID: 38066564
  • Angelos MG, Ballard HJ, Barta SK. Advances and Personalized Approaches in the Frontline Treatment of T-Cell Lymphomas. J Pers Med. 2022 Feb 11;12(2). PubMed PMID: 35207754

Professional Memberships

  • American Society of Hematology, Member
  • American Society for Transplantation and Cellular Therapy, Member

Practice Locations

UCHealth Blood Disorders and Cell Therapies Center - Anschutz Medical Campus
1665 Aurora Court
3rd floor, Anschutz Cancer Pavilion
Aurora, CO 80045
720-848-6400

UCHealth Anschutz Inpatient Pavilion - Anschutz Medical Campus
12605 E. 16th Ave
Aurora, CO 80045
720-848-0000

Hospital Affiliation
  • University of Colorado Hospital

Specialty Information

Specialties
  • Internal Medicine, Board Certification (2021)
  • Medical Oncology, Board Certification (2024)
Conditions & Treatments
  • Cancers - Leukemia (Adult Acute)
  • Cancers
  • Cancers - Leukemia (Adult Chronic)
  • Cancers - Blood and Marrow Transplant
  • Cancers - Myelodysplastic Syndrome